Below is Validea's guru fundamental report for SABRA HEALTH CARE REIT INC (SBRA). Of the 22 guru strategies we follow, SBRA rates highest using our Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
SABRA HEALTH CARE REIT INC (SBRA) is a mid-cap growth stock in the Real Estate Operations industry. The rating using this strategy is 64% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
MARKET CAP: | PASS |
EARNINGS TREND: | FAIL |
EPS GROWTH RATE IN THE IMMEDIATE PAST AND FUTURE: | PASS |
P/E RATIO: | FAIL |
PRICE/CASH FLOW (P/CF) RATIO: | FAIL |
PRICE/BOOK (P/B) VALUE: | FAIL |
PRICE/DIVIDEND (P/D) RATIO: | PASS |
CURRENT RATIO: | FAIL |
PAYOUT RATIO: | PASS |
RETURN ON EQUITY: | FAIL |
PRE-TAX PROFIT MARGINS: | PASS |
YIELD: | PASS |
LOOK AT THE TOTAL DEBT/EQUITY: | PASS |
Detailed Analysis of SABRA HEALTH CARE REIT INC
More Information on David Dreman
About David Dreman: Dreman's Kemper-Dreman High Return Fund was one of the best-performing mutual funds ever, ranking as the best of 255 funds in its peer groups from 1988 to 1998, according to Lipper Analytical Services. At the time Dreman published Contrarian Investment Strategies: The Next Generation, the fund had been ranked number one in more time periods than any of the 3,175 funds in Lipper's database. In addition to managing money, Dreman is also a longtime Forbes magazine columnist.
Additional Research Links
High Free Cash Flow Yield Stocks
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.